Skip to main content

Advertisement

SpringerLink
Log in

Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Human leukocyte antigen (HLA)-G is a non-classical HLA class I molecule that exerts a generalized immunosuppressive action. A deficit in membrane bound and soluble HLA-G levels seems to cause a defective control on immune responses and trigger off several autoimmune diseases. As psoriasis is considered an autoimmune disease, lower levels of soluble HLA-G (sHLA-G) might be expected in psoriatic patients than in healthy controls. The aims of this descriptive study were: (1) to evaluate whether sHLA-G levels are different in psoriatic patients compared to controls; (2) to compare sHLA-G levels between groups of patients treated with different therapies; (3) to evaluate whether any differences found in HLA-G expression could be related to a genetic control. Peripheral blood samples were investigated for sHLA-G and IL-10 levels and for HLA-G 14 bp polymorphism in 65 patients with moderate-to-severe plaque psoriasis treated with systemic drugs or with topical or physical treatments and in controls. Significantly lower plasma levels of both sHLA-G and IL-10 were found in psoriatic group compared to controls and in local treated patients in comparison with systemic treated patients. These findings could indicate that low sHLA-G levels may contribute to susceptibility to psoriasis. Absence of differences in HLA-G 14 bp allele and genotype frequencies between psoriatic patients and controls and between patients following different treatments seems to exclude genetic bases of sHLA-G levels. It could be speculated that therapeutics antagonizing systemic T helper 1 activation may induce sHLA-G secretion via an IL-10-dependent pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

HLA-G:

Human leukocyte antigen-G

sHLA-G:

Soluble human leukocyte antigen-G

Th1:

T helper 1

Th17:

T helper 17

PASI:

Psoriasis area and severity index

LFA-1:

Lymphocyte function antigen-1

ICAM-1:

Intercellular adhesion molecule-1

References

  1. Aractingi S, Briand N, Le Danff C, Viguier M, Bachelez H, Michel L, Dubertret R, Carosella ED (2001) HLA-G and NK receptors are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Am J Pathol 159:71–77

    PubMed  CAS  Google Scholar 

  2. Asadullah K, Sterry W, Stephanek K, Jasulaitis D, Leupold M, Audring H, Volk HD, Döcke WD (1998) IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J Clin Invest 101:783–794

    Article  PubMed  CAS  Google Scholar 

  3. Asadullah K, Döcke WD, Ebeling M, Friedrich M, Belbe G, Audring H, Volk HD, Sterry W (1999) Interleukin 10 treatment of psoriasis. Clinical results of a phase 2 trial. Arch Dermatol 135:187–192

    Article  PubMed  CAS  Google Scholar 

  4. Baindbridge DR, Ellis SA, Sargent IL (2000) HLA-G suppresses proliferation of CD4+ T lymphocytes. J Reprod Immunol 48:17–26

    Article  Google Scholar 

  5. Baricordi OR, Govoni M, Rizzo R, Trotta F (2007) In rheumatoid arthritis, a polymorphism in the HLA-G gene concurs in the clinical response to methotrexate treatment. Ann Rheum Dis 66:1125–1126

    Article  PubMed  Google Scholar 

  6. Bowcock AM, Krueger JG (2005) Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 5:699–711

    Article  PubMed  CAS  Google Scholar 

  7. Brown DW, Baker BS, Ovigne JM, Hardman C, Powles AV, Fry L (2000) Skin CD4+ T cells produce interferon-gamma in vitro in response to streptococcal antigens in chronic plaque psoriasis. J Invest Dermatol 114:576–580

    Article  PubMed  CAS  Google Scholar 

  8. Carosella ED, Moreau P, Aractingi S, Rouas-Freiss N (2001) HLA-G: a shield against inflammatory aggression. Trends Immunol 22:553–555

    Article  PubMed  CAS  Google Scholar 

  9. Chong FC, Wong HK (2007) Immunobiologics in the treatment of psoriasis. Clin Immunol 123:129–138

    Article  PubMed  CAS  Google Scholar 

  10. Creput C, Le Friec G, Bahri R, Amiot L, Charpentier B, Carosella ED, Rouas-Freiss N, Durrbach A (2003) Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver- kidney transplantation: possible implications for monitoring patients. Hum Immunol 11:1033–1038

    Article  Google Scholar 

  11. Dawe RS, Cameron H, Yule S, Man I, Ibbotson SH, Ferguson J (2002) UV-B phototherapy clears psoriasis through local effects. Arch Dermatol 138:10171–10176

    Article  Google Scholar 

  12. Elkayam O, Yaron I, Shirazi I, Yaron M, Caspi D (2000) Serum levels of IL-10, IL-6, IL-1R and sIL-2R in patients with psoriatic arthritis. Rheumatol Int 19:101–105

    Article  PubMed  CAS  Google Scholar 

  13. Fainardi E, Rizzo R, Melchiorri L, Vaghi L, Castellazzi M, Marzola A, Govoni V, Paolino E, Tola MR, Granieri E, Baricordi OR (2003) Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings. J Neuroimmunol 142:149–158

    Article  PubMed  CAS  Google Scholar 

  14. Fournel S, Aguerre-Girr M, Huc X, Lenfant F, Alam A, Toubert A, Bensussan A, Le Bouteiller P (2000) Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 164:6100–6104

    PubMed  CAS  Google Scholar 

  15. Friedrich M, Döcke WD, Klein A, Philipp S, Volk HD, Sterry W, Asadullah H (2002) Immunomodulation by Interleukin-10 therapy decreases the incidence of relapse and prolongs the relapse-free interval in psoriasis. J Invest Dermatol 118:672–677

    Article  PubMed  CAS  Google Scholar 

  16. Gazit E, Slomov Y, Goldberg I, Brenner S, Loewenthal R (2004) HLA-G is associated with pemphigus vulgaris in Jewish patients. Hum Immunol 65:39–46

    Article  PubMed  CAS  Google Scholar 

  17. Horuzko A, Lenfant F, Munn DH, Mellor AL (2001) Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Int Immunol 13:385–394

    Article  Google Scholar 

  18. Hviid TV, Hylenius S, Rorbye C, Nielsen LG (2003) HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 55:63–79

    PubMed  CAS  Google Scholar 

  19. Hviid TV, Rizzo R, Christiansen OB, Melchiorri L, Lindhard A, Baricordi OR (2004) HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics 56:135–141

    Article  PubMed  CAS  Google Scholar 

  20. Hviid TV, Hylenius S, Hoegh AM, Kruse C, Christiansen OB (2002) HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens 60:122–132

    Article  PubMed  CAS  Google Scholar 

  21. Jacob SE, Nassiri M, Kerdel FA, Vincek V (2003) Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity. Mediators Inflamm 12:309–313

    Article  PubMed  CAS  Google Scholar 

  22. Jullien D, Prinz JC, Langley RG, Caro I, Dummer W, Joshi A, Dedrick R, Natta P (2004) T-cell modulation for the treatment of chronic plaque psoriasis with Efalizumab (Raptiva): mechanisms of action. Dermatology 208:297–306

    Article  PubMed  CAS  Google Scholar 

  23. Khosrotehrani K, Le Danff C, Reynaud-Mendel B, Dubertret L, Carosella ED, Aractingi S (2001) HLA-G expression in atopic dermatitis. J Invest Dermatol 17:750–752

    Article  Google Scholar 

  24. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R (1990) A class I antigen, HLA-G, expressed in human trophoblasts. Science 248:220–223

    Article  PubMed  CAS  Google Scholar 

  25. Lefebvre S, Berrih-Akin S, Adrian F, Moreau P, Poea S, Gourand L, Dausset J, Carosella ED, Paul P (2001) A specific interferon (IFN)-stimulated response element of the distal HLA-G promoter binds IFN-regulatory factor 1 and mediates enhancement of this nonclassical class I gene by IFN-beta. J Biol Chem 276:6133–6139

    Article  PubMed  CAS  Google Scholar 

  26. Le Friec G, Laupeze B, Fardel O, Sebti Y, Pangault C, Guilloux V, Beauplet A, Fauchet R, Amiot L (2003) Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes. Human Immunol 64:752–761

    Article  CAS  Google Scholar 

  27. Lew W, Bowcock AM, Krueger JG (2004) Psoriasis vulgaris: cutaneous lymphoid tissue supports T-cell activation and “Type 1” inflammatory gene expression. Trends Immunol 25:295–305

    Article  PubMed  CAS  Google Scholar 

  28. Lila N, Amrein C, Guillemain R, Chevalier P, Latremouille C, Fabiani JN, Dausset J, Carosella ED, Carpentier A (2002) Human leukocyte antigen -G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 105:1949–1954

    Article  PubMed  Google Scholar 

  29. LeMaoult J, Le Discorde M, Rouas-Freiss N, Moreau P, Menier C, McCluskey J, Carosella ED (2003) Biology and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens 62:273–284

    Article  PubMed  CAS  Google Scholar 

  30. LeMaoult J, Krawice-Radanne I, Dausset J, Carosella ED (2004) HLA-G1-espressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Prot Natl Acad Sci USA 101:7064–7069

    Article  CAS  Google Scholar 

  31. Lozano JM, Gonzales R, Kindelan JM, Rouas-Freiss N, Caballos R, Dausset J, Carosella ED, Peňa J (2002) Monocytes and T lymphocytes in HIV-1 positive patients express HLA-G molecules. AIDS 16:347–351

    Article  PubMed  CAS  Google Scholar 

  32. Maier S, Geraghty DE, Weiss EH (1999) Expression and regulation of HLA-G in human glioma cells. Transplant Proc 41:1849–1853

    Article  Google Scholar 

  33. Mehlis SL, Gordon KB (2003) The immunology of psoriasis and biologic immunotherapy. J Am Acad Dermatol 49:S44–S50

    Article  PubMed  Google Scholar 

  34. Moreau P, Adrian-Cabestre F, Menier C, Guiard U, Gourand L, Dausset J, Carosella ED, Paul P (1999) IL-10 selectively induces HLA-G expression in human trophoblast and monocytes. Int Immunol 5:803–811

    Article  Google Scholar 

  35. Nickoloff BJ, Jian-Zhong Q, Nestle FO (2007) Immunopathogenesis of psoriasis. Clin Rev Allergy Immunol 33:45–56

    Article  PubMed  CAS  Google Scholar 

  36. Nickoloff BJ, Fivenson DP, Kunkel SL, Strieter RM, Turka LA (1994) Keratinocyte IL-10 expression is upregulated in tape-stripped skin, poison ivy dermatitis, and Sezary syndrome, but not in psoriatic plaques. Clin Immunol Immunopathol 73:63–68

    Article  PubMed  CAS  Google Scholar 

  37. Onno M, Pangault C, Le Friec G, Guilloux V, Andre P, Fauchet R (2000) Modulation of HLA-G antigen expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 164:6426–6434

    PubMed  CAS  Google Scholar 

  38. Paul P, Rouas-Freiss N, Khalil-Daher I, Moreau P, Riteau B, Le Gal FA, Avril MF, Dausset J, Guillet JG, Carosella ED (1998) HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 95:4510–4515

    Article  PubMed  CAS  Google Scholar 

  39. Paul P, Cabestre FA, Le Gal FA, Khalil-Daher I, Le Danff C, Shmid M, Mercier S, Avril MF, Dausset J, Guillet JG, Carosella ED (1999) Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies. Cancer Res 59:1954–1960

    PubMed  CAS  Google Scholar 

  40. Rebmann V, van der Ven K, Passler M, Pfeiffer K, Krebs D, Grosse-Wilde H (2001) Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 57:15–21

    Article  PubMed  CAS  Google Scholar 

  41. Rebmann V, LeMaoult J, Rouas-Freiss N, Carosella ED, Grosse-Wilde H (2007) Quantification and identification of soluble HLA-G isoforms. Tissue Antigens 69:143–149

    Article  PubMed  CAS  Google Scholar 

  42. Rouas-Freiss N, Marchal RE, Kirszenbaum M, Dausset J, Carosella ED (1997) The α1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci USA 94:5249–5254

    Article  PubMed  CAS  Google Scholar 

  43. Roussaki-Schulze AV, Kouskoukis C, Petinaki E, Klimi E, Zafiriou E, Galanos A, Rallis E (2005) Evaluation of cytokine serum levels in patients with plaque-type psoriasis. Int J Clin Pharmacol Res 25:169–173

    PubMed  CAS  Google Scholar 

  44. Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P (2003) The 14 bp deletion-insertion polymorphism in the 3’ UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 64:1005–1010

    Article  PubMed  CAS  Google Scholar 

  45. Sabat R, Philipp S, Höflich C, Kreutzer S, Wallace E, Asadullah K, Volk HD, Sterry W, Wolk K (2007) Immunopathogenesis of psoriasis. Exp Dermatol 16:779–798

    Article  PubMed  CAS  Google Scholar 

  46. Sugijama H, Gyulai R, Toichi E, Garaczi E, Shimada S, Stevens SR, McCormick TS, Cooper KD (2005) Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 174:164–173

    Google Scholar 

  47. Urosevic M (2007) HLA-G in the skin. Friend or foe ? Semin Cancer Biol 17:480–484

    PubMed  CAS  Google Scholar 

  48. Verbruggen LA, Rebman V, Demanet C, De Cock S, Grosse-Wilde H (2006) Soluble HLA-G in rheumatoid arthritis. Hum Immunol 67:561–567

    Article  PubMed  CAS  Google Scholar 

  49. Weisenseel P, Prinz JC (2005) Incidental detection of S. pyogenes-DNA in psoriatic skin by PCR. Arch Dermatol Res 296:573–576

    Article  PubMed  CAS  Google Scholar 

  50. Yie SM, Xiao R, Librach CL (2006) Progesterone enhances HLA-G gene expression in JEG-3 choriocarcinoma cells and human cytotrophoblasts in vitro. Hum Reprod 1:46–51

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical and Experimental Medicine, Section of Dermatology, University of Ferrara, Via Savonarola 9, 44100, Ferrara, Italy

    Alessandro Borghi, Emanuela Fogli, Ermete Altieri & Annarosa Virgili

  2. Department of Experimental and Diagnostic Medicine, Section of Medical Genetics, University of Ferrara, Via L. Borsari 46, 44100, Ferrara, Italy

    Marina Stignani, Loredana Melchiorri, Olavio Baricordi & Roberta Rizzo

Authors
  1. Alessandro Borghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emanuela Fogli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marina Stignani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Loredana Melchiorri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ermete Altieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Olavio Baricordi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Roberta Rizzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Annarosa Virgili
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Annarosa Virgili.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Borghi, A., Fogli, E., Stignani, M. et al. Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease. Arch Dermatol Res 300, 551–559 (2008). https://doi.org/10.1007/s00403-008-0886-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-008-0886-6

Keywords

Search

Navigation